Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis
ConclusionBenznidazole had a poor tolerability profile, with a high incidence of TDs, especially in adult patients and women. Optimised dosing schedules and/or new drugs are urgently needed.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Chagas Disease | Children | Clinical Trials | Drugs & Pharmacology | Gastroenterology | Neurology | Skin | Study | Toxicology | Women